Genetics: What advice for patients who present with a family history of melanoma?

被引:15
作者
Bishop, Julia A. Newton [1 ]
Gruis, Nelleke A. [2 ]
机构
[1] St James Hosp, Leeds Inst Mol Med, Epidemiol & Biostat Sect, Leeds LS9 7TF, W Yorkshire, England
[2] Leiden Univ, Med Ctr, Skin Res Lab, Leiden, Netherlands
关键词
D O I
10.1053/j.seminoncol.2007.09.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A significantly increased susceptibility to melanoma may manifest as a family history of melanoma (plus or minus pancreatic cancer), the development of multiple primary tumors, or melanoma in the context of numerous and clinically atypical moles (the atypical mole syndrome). In families, increased susceptibility may occur as a result of the inheritance of mutations at the CDKN2A locus or in the CDK4 gene. We describe what is known about these genes and discuss the implications for genetic counseling and gene testing. Lower levels of risk are associated with genetically determined pigmentary variation within populations. This variation is attributable to inheritance of variants in the MC1R gene and putatively other genes such as OCA2, which is discussed. Melanoma is causally related to sun exposure in the majority of patients, although the patterns of sun exposure, which are most important, remain controversial. The role of risk estimation for individuals in giving advice about sun exposure is considered.
引用
收藏
页码:452 / 459
页数:8
相关论文
共 82 条
[71]  
Rebbeck TR, 2002, CANCER EPIDEM BIOMAR, V11, P782
[72]   p14ARF interacts with the SUMO-conjugating enzyme Ubc9 and promotes the sumoylation of its binding partners [J].
Rizos, H ;
Woodruff, S ;
Kefford, RF .
CELL CYCLE, 2005, 4 (04) :597-603
[73]   A melanoma-associated germline mutation in exon 1β inactivates p14ARF [J].
Rizos, H ;
Puig, S ;
Badenas, C ;
Malvehy, J ;
Darmanian, AP ;
Jiménez, L ;
Milà, M ;
Kefford, RF .
ONCOGENE, 2001, 20 (39) :5543-5547
[74]   Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France [J].
Soufir, N ;
Avril, MF ;
Chompret, A ;
Demenais, F ;
Bombled, J ;
Spatz, A ;
Stoppa-Lyonnet, D ;
Bénard, J ;
Bressac-de Paillerets, B .
HUMAN MOLECULAR GENETICS, 1998, 7 (02) :209-216
[75]  
Tonin PN, 2000, SEMIN SURG ONCOL, V18, P281, DOI 10.1002/(SICI)1098-2388(200006)18:4<281::AID-SSU2>3.0.CO
[76]  
2-Q
[77]   The Asp84Glu variant of the melanocortin 1 receptor (MC1R) is associated with melanoma [J].
Valverde, P ;
Healy, E ;
Sikkink, S ;
Haldane, F ;
Thody, AJ ;
Carothers, A ;
Jackson, IJ ;
Rees, JL .
HUMAN MOLECULAR GENETICS, 1996, 5 (10) :1663-1666
[78]   VARIANTS OF THE MELANOCYTE-STIMULATING HORMONE-RECEPTOR GENE ARE ASSOCIATED WITH RED HAIR AND FAIR SKIN IN HUMANS [J].
VALVERDE, P ;
HEALY, E ;
JACKSON, I ;
REES, JL ;
THODY, AJ .
NATURE GENETICS, 1995, 11 (03) :328-330
[79]   Melanocortin-1 receptor variant R151C modifies melanoma risk in Dutch families with melanoma [J].
van der Velden, PA ;
Sandkuijl, LA ;
Bergman, W ;
Pavel, S ;
van Mourik, L ;
Frants, RR ;
Gruis, NA .
AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 69 (04) :774-779
[80]   Heritability and gene-environment interactions for melanocytic nevus density examined in a UK adolescent twin study [J].
Wachsmuth, RC ;
Gaut, RM ;
Barrett, JH ;
Saunders, CL ;
Randerson-Moor, JA ;
Eldridge, A ;
Martin, NG ;
Bishop, T ;
Bishop, JAN .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2001, 117 (02) :348-352